Table 2.
Abdominal pain severity scores over the intervention period.
| Mean (SD) | p Value † | |||||
|---|---|---|---|---|---|---|
| Placebo (n = 109) |
L. acidophilus DDS-1 (n = 111) |
B. lactis UABla-12 (n = 110) |
DDS-1 vs. Placebo | UABla-12 vs. Placebo | DDS-1 vs. UABla-12 |
|
| APS-NRS Score | ||||||
| Day 0 | 6.94 (1.02) | 7.03 (0.99) | 6.84 (1.04) | 0.499 | 0.412 | 0.155 |
| AbsΔ (Day 21) | −0.71 (0.92) | −1.24 (1.10) | −0.88 (0.99) | < 0.001 | 0.178 | 0.012 |
| AbsΔ (Day 42) | −0.85 (1.45) | −2.59 (2.07) | −1.56 (1.83) | 0.001 | 0.001 | < 0.001 |
† Between group comparison, Mann–Whitney U test; APS-NRS: Abdominal Pain Severity – Numeric Rating Scale; AbsΔ: absolute change.